✦ LIBER ✦

Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids

✍ Scribed by Weiler, R. ;Feichtinger, H. ;Schmid, K. W. ;Fischer-Colbrie, R. ;Grimelius, L. ;Cedermark, B. ;Papotti, M. ;Bussolati, G. ;Winkler, H.

Book ID: 104903173
Publisher: Springer-Verlag
Year: 1987
Tongue: English
Weight: 790 KB
Volume: 412
Category: Article
ISSN: 0174-7398
DOI: 10.1007/bf00716181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secretoneurin in bronchopulmonary carcin

Secretoneurin in bronchopulmonary carcinoids—immunohistochemical comparison with chromogranins A and B and secretogranin II

✍ M. TÖTSCH; B-C. PADBERG; S. SCHRÖDER; D. ÖFNER; W. BÖCKER; R. FISCHER-COLBRIE; K 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 941 KB

Differential regulation of chromogranin

Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment

✍ J Marksteiner; U Weiss; C Weis; A Laslop; R Fischer-Colbrie; C Humpel; J Feldon; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 573 KB

Distribution of chromogranins A and B an

Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens

✍ J.-Y Li; B Leitner; H Winkler; A Dahlström 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Chromogranin in endocrine cells and carc

Chromogranin in endocrine cells and carcinoids of small intestine

✍ M. Lundqvist; E. Wilander; M. Malmgren; B. Eriksson; K. Öberg 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Levels and proteolytic processing of chr

Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases

✍ U. Eder; B. Leitner; R. Kirchmair; P. Pohl; K. A. Jobst; A. D. Smith; J. Mélly; 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 315 KB

Chromogranin A and B and secretogranin I

Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: Neuroendocrine expression in patients untreated and treated with androgen deprivation therapy

✍ Pruneri, Giancarlo; Galli, Stefano; Rossi, Roberta S.; Roncalli, Massimo; Coggi, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

BACKGROUND. Neuroendocrine (NE) expression in prostatic adenocarcinomas (PACs) has been related to an adverse clinical course, but the reported data are not unequivocal. METHODS. We immunostained a series of 64 PACs with three monoclonal antibodies raised against chromogranin A (CgA), chromogranin B